Literature DB >> 1402654

Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: evidence for inefficient peptide binding.

M Ulbrecht1, J Kellermann, J P Johnson, E H Weiss.   

Abstract

The assembly of the classical, polymorphic major histocompatibility complex class I molecules in the endoplasmic reticulum requires the presence of peptide ligands and beta 2-microglobulin (beta 2m). Formation of this trimolecular complex is a prerequisite for efficient transport to the cell surface, where presented peptides are scanned by T lymphocytes. The function of the other class I molecules is in dispute. The human, nonclassical class I gene, HLA-E, was found to be ubiquitously transcribed, whereas cell surface expression was difficult to detect upon transfection. Pulse chase experiments revealed that the HLA-E heavy chain in transfectants, obtained with the murine myeloma cell line P3X63-Ag8.653 (X63), displays a significant reduction in oligosaccharide maturation and intracellular transport compared with HLA-B27 in corresponding transfectants. The accordingly low HLA-E cell surface expression could be significantly enhanced by either reducing the culture temperature or by supplementing the medium with human beta 2m, suggesting inefficient binding of endogenous peptides to HLA-E. To analyze whether HLA-E binds peptides and to identify the corresponding ligands, fractions of acid-extracted material from HLA-E/X63 transfectants were separated by reverse phase HPLC and were tested for their ability to enhance HLA-E cell surface expression. Two fractions specifically increased the HLA class I expression on the HLA-E transfectant clone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402654      PMCID: PMC2119380          DOI: 10.1084/jem.176.4.1083

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Cellular peptide composition governed by major histocompatibility complex class I molecules.

Authors:  K Falk; O Rötzschke; H G Rammensee
Journal:  Nature       Date:  1990-11-15       Impact factor: 49.962

2.  Which came first, MHC class I or class II?

Authors:  M F Flajnik; C Canel; J Kramer; M Kasahara
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

3.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution.

Authors:  M A Saper; P J Bjorkman; D C Wiley
Journal:  J Mol Biol       Date:  1991-05-20       Impact factor: 5.469

4.  Structure, expression, and molecular mapping of a divergent member of the class I HLA gene family.

Authors:  R Srivastava; M J Chorney; S K Lawrance; J Pan; Z Smith; C L Smith; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

5.  Recognition of the product of a novel MHC TL region gene (27b) by a mouse gamma delta T cell receptor.

Authors:  K Ito; L Van Kaer; M Bonneville; S Hsu; D B Murphy; S Tonegawa
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

6.  Maternally transmitted histocompatibility antigen of mice: a hydrophobic peptide of a mitochondrially encoded protein.

Authors:  B Loveland; C R Wang; H Yonekawa; E Hermel; K F Lindahl
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

7.  The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.

Authors:  J Alexander; J A Payne; B Shigekawa; J A Frelinger; P Cresswell
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

8.  Differential expression of HLA-E, HLA-F, and HLA-G transcripts in human tissue.

Authors:  X H Wei; H T Orr
Journal:  Hum Immunol       Date:  1990-10       Impact factor: 2.850

9.  Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.

Authors:  S A Ellis; M S Palmer; A J McMichael
Journal:  J Immunol       Date:  1990-01-15       Impact factor: 5.422

10.  Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta.

Authors:  S M Shawar; R G Cook; J R Rodgers; R R Rich
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.

Authors:  T Kevin Howcroft; Dinah S Singer
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

2.  HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.

Authors:  W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  Allelic repertoire of the human MHC class I MICA gene.

Authors:  N Fodil; L Laloux; V Wanner; P Pellet; G Hauptmann; N Mizuki; H Inoko; T Spies; I Theodorou; S Bahram
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  The MHC E locus in macaques is polymorphic and is conserved between macaques and humans.

Authors:  J E Boyson; S N McAdam; A Gallimore; T G Golos; X Liu; F M Gotch; A L Hughes; D I Watkins
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

5.  A new marker in the HLA class I region is associated with the age at onset of IDDM.

Authors:  A G Demaine; M L Hibberd; D Mangles; B A Millward
Journal:  Diabetologia       Date:  1995-05       Impact factor: 10.122

6.  High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.

Authors:  Maria Benevolo; Marcella Mottolese; Elisa Tremante; Francesca Rollo; Maria Grazia Diodoro; Cristiana Ercolani; Isabella Sperduti; Elisa Lo Monaco; Maurizio Cosimelli; Patrizio Giacomini
Journal:  J Transl Med       Date:  2011-10-27       Impact factor: 5.531

7.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

8.  Availability of endogenous peptides limits expression of an M3a-Ld major histocompatibility complex class I chimera.

Authors:  J M Vyas; R R Rich; D D Howell; S M Shawar; J R Rodgers
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

Review 9.  Role of non-classical MHC class I molecules in cancer immunosuppression.

Authors:  Grazyna Kochan; David Escors; Karine Breckpot; David Guerrero-Setas
Journal:  Oncoimmunology       Date:  2013-10-21       Impact factor: 8.110

10.  The Role of MHC-E in T Cell Immunity Is Conserved among Humans, Rhesus Macaques, and Cynomolgus Macaques.

Authors:  Helen L Wu; Roger W Wiseman; Colette M Hughes; Gabriela M Webb; Shaheed A Abdulhaqq; Benjamin N Bimber; Katherine B Hammond; Jason S Reed; Lina Gao; Benjamin J Burwitz; Justin M Greene; Fidel Ferrer; Alfred W Legasse; Michael K Axthelm; Byung S Park; Simon Brackenridge; Nicholas J Maness; Andrew J McMichael; Louis J Picker; David H O'Connor; Scott G Hansen; Jonah B Sacha
Journal:  J Immunol       Date:  2017-11-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.